AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
7.92
-0.22 (-2.70%)
Apr 1, 2025, 10:21 AM EDT - Market open
AVITA Medical Revenue
In the year 2024, AVITA Medical had annual revenue of $64.25M with 28.14% growth. AVITA Medical had revenue of $18.41M in the quarter ending December 31, 2024, with 29.67% growth.
Revenue (ttm)
$64.25M
Revenue Growth
+28.14%
P/S Ratio
3.28
Revenue / Employee
$247,119
Employees
260
Market Cap
208.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
Dec 31, 2022 | 34.42M | 1.40M | 4.23% |
Dec 31, 2021 | 33.03M | 3.79M | 12.98% |
Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
Jun 30, 2020 | Pro | Pro | Pro |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RCEL News
- 14 days ago - AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific - GlobeNewsWire
- 4 weeks ago - AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - After Sales Rebound In January, AVITA Is Set Up For A Monster Year - Seeking Alpha
- 6 weeks ago - AVITA Medical to Host Investor Webinar Briefing - GlobeNewsWire
- 6 weeks ago - AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish - Seeking Alpha
- 2 months ago - AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini - Seeking Alpha